GRAS Path Draws Interest As NDI Alternative, But Carries Challenges
This article was originally published in The Tan Sheet
Executive Summary
In the wake of FDA’s draft guidance on NDI notifications, more companies reevaluate the status of their ingredients before going to market. The GRAS for use in foods process is a clear – but rigorous – alternative pathway.
You may also be interested in...
NDI Notification Draft Guidance Seminar In Brief
History of use, toxicology studies key
Transparency Sought From FDA In GRAS Notification Filing Decisions
FDA should clarify its criteria for rejecting generally recognized as safe notifications for food ingredients voluntarily submitted by companies, a consulting firm tells the agency.